IGC Pharma, Inc. (IGC)
IGC Pharma, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
IGC Pharma, Inc. (IGC) is a Biotechnology company based in US with a market capitalization of $26.7M. Revenue declined 6.7% year-over-year and free cash flow was negative at -$6.1M. This page tracks IGC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 67 employees · IPO May 24, 2006
Valuation
Valuation & price
$0.29as of May 17, 2026· -39.1% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
4.37
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$26.7M
Market cap
-6.7%
Revenue growth (YoY)
29.7%
Gross margin
-$6.1M
Free cash flow (USD)
-$207K
Net debt
Net cash position
24.2%
Share dilution
1/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2026
Free cash flow by year
2017 → 2026
Gross margin by year
2022 → 2026
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: Jun 26, 2026 (EPS $-0.02)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is IGC Pharma, Inc.'s market cap?
IGC Pharma, Inc. (IGC) has a market capitalization of $26.7M.
What is IGC's P/E ratio?
A meaningful P/E ratio is not available for IGC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is IGC's price-to-book (P/B) ratio?
IGC trades at 4.37 times book value per share.
When did IGC Pharma, Inc. last report earnings?
IGC last reported earnings on June 26, 2026; the next date is not yet scheduled.
Are insiders buying IGC stock?
SEC Form 4 filings show no open-market insider buys at IGC Pharma, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.